Professor, Psychiatry, UCLA School of Medicine
Psychiatry
Dr. Walter Ling, MD
Walter Ling practices Psychiatry. Dr. Walter Ling is also published. He has 24 publications published. The lastest publication: "Short term health-related quality of life improvement during opioid agonist treatment.' Walter Ling is registered with Medicare.
Publications
- Short term health-related quality of life improvement during opioid agonist treatment.
- Using behavioral economics to predict opioid use during prescription opioid dependence treatment.
- Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study.
- Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users.
- HIV Risk Reduction With Buprenorphine-Naloxone or Methadone: Findings From A Randomized Trial.
- Sustained-Release Methylphenidate in a Randomized Trial of Treatment of Methamphetamine Use Disorder.
- Medication-assisted therapy for opioid addiction.
- Medication-assisted treatment for opioid addiction: methadone and buprenorphine.
- Commentary on Brooner et al. (2013): one-stop shopping--what sells and what doesn't.
- Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females.
- Comparison of behavioral treatment conditions in buprenorphine maintenance.
- The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample.
- Treatment Retention among Patients Randomized to Buprenorphine/Naloxone Compared to Methadone in A Multi-site Trial.
- Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist rep...
- An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.
- Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: A randomized trial.
- A Comparison of Buprenorphine Taper Outcomes Between Prescription Opioid and Heroin Users.
- Cocaine Use Reduction with Buprenorphine (CURB): Rationale, design, and methodology.
- Predictors of outcome after short-term stabilization with buprenorphine.
- Advances in opioid antagonist treatment for opioid addiction.
- Comparisons of Analgesic Potency and Side Effects of Buprenorphine and Buprenorphine With Ultra-low-dose Naloxone.
- Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy.
- Long-term course of opioid addiction.
Doctors Specialties
- Neurology
- Psychiatry
Accepted Insurances
Education
-
Chulalongkorn University Faculty of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Jeff M. Bronstein, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Franklin H. Dines, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Praveen R. Kambam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert S. Martin, MD |
|
|
Dr. Stephanie L. Geller, MD |
|
|
Dr. Isaac Melguizo-Gavilanes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Markus Horvath, MD |
|
|
Dr. Mani K. Nezhad, MD |
|
|
Dr. Vandana Chopra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan Markie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Man C. Cho, MD |
|
|
Dr. Mariel B. Deutsch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Po-Haong Lu, PHD |